Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.10.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Revenue $ 0 $ 0
Operating expenses:    
Research and development 9,728 4,545
General and administrative 5,229 4,090
Depreciation 68 18
Total operating expenses 15,025 8,653
Loss from operations (15,025) (8,653)
Other income (expense):    
Gain (loss) from change in fair value of warrant liability 3,185 (2,548)
Gain from settlement of liability 0 149
Gain from expiration of warrants 0 1,238
Other (expense) income (40) 9
Interest income (expense), net 4 0
Net loss $ (11,876) $ (9,805)
Net loss per common share - basic and diluted (in dollars per share) $ (0.46) $ (0.53)
Weighted average common shares outstanding, basic and diluted 25,904,170 18,569,193
Other comprehensive income (loss):    
Foreign currency translation $ 35 $ 0
Comprehensive loss $ (11,841) $ (9,805)